NBY NOVABAY PHARMACEUTICALS INC Company Mergers 8-K Filing 2024 - Asset Sale Update NovaBay Pharmaceuticals amended its agreement to sell its Avenova eyecare products to PRN, increasing the sale price from $9.5 million to $11.5 million and securing a $1 million loan for working capital.Get access to all SEC 8-K filings of the NOVABAY PHARMACEUTICALS INC